Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.
G
0%
3-year Growth Rate
R
4/5
3-year Risk Analysis
O
0%
Outlook 12/24
W
N/A
Margin of safety
T
-100%
Analyst Price Target
H
UP
50-week EMA Trend
It is not possible to show the GROWTH analysis for a period of five years. Showing the analysis for a period of three years instead.
Company Info
EPS Growth 5Y
29,53%
Revenue growth 5Y
2,37%
Price growth 5Y
68,95%
Market Cap
¥14,53 B
Long-Term Debt
¥0,01 B
Quarterly earnings
04/23/2026
Dividend
¥0,00
Dividend Yield
0,00%
Industry
Country
ISIN Number
Vcanbio Cell & Gene Engineering Corp., Ltd Price Chart
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
There are currently no price targets available for this stock.
Top growth stocks in the health care sector
| Stock | Rate of Return 5Y | Price 5Y | Div. 5Y | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|---|---|
|
Vcanbio Cell & Gene Engineerin...
SHSE:600645
|
68,95% | 68,95% | 0,00% | 0,00% | 4/5 | 0,00% | 0,00% | -100,00% | UP |
